Proper Name: Influenza Vaccine
Tradename: Flublok Quadrivalent
Manufacturer: Protein Sciences Corporation
- Indicated for active immunization against disease caused by influenza virus subtypes A and type B contained in the vaccine. Flublok is approved for use in persons 18 years of age and older.
October 7, 2016 Approval Letter - Flublok Quadrivalent(PDF - 103KB)
To include a quadrivalent formulation (Flublok Quadrivalent).
October 7, 2016 Summary Basis for Regulatory Action - Flublok Quadrivalent(PDF - 172KB)